-

Northwell Kidney Transplant Program Rated Nation’s Best for 1-year Survival

North Shore University Hospital’s expected survival rate 60 percent better than national average

MANHASSET, N.Y.--(BUSINESS WIRE)--The Northwell Health Transplant Center at North Shore University Hospital (NSUH) has been rated the No. 1 kidney transplant program in the nation for one-year survival of transplant recipients, according to the latest report from the Scientific Registry of Transplant Recipients (SRTR).

The superior outcomes of NSUH’s kidney transplant program are based on data from more than 40,000 transplants at 250 programs nationwide between July 2018 to December 2020. The SRTR evaluates the status of the solid organ transplant system in the United States and publicly releases the data at the directive of the U.S. Department of Health and Human Services using Bayesian statistical methodology.

“These outcomes are a reflection of the outstanding care our patients receive across the entire transplant journey, from evaluation, surgery, postoperative care and long term follow up,” said Nabil N. Dagher, MD, FACS, vice president and director of the Northwell Health Transplant Center, where he oversees its liver and kidney transplant programs. “Northwell’s kidney transplant program now has a national reputation for excellence and should be considered a destination for anyone with kidney disease.”

NSUH performed 225 kidney transplants during the observed 30-month span, according to SRTR data. Northwell’s estimated hazard ratio was 0.39, which was 60 percent below the national expected death rate of 1.0. A ratio greater than 1.0 indicates that more deaths occurred than would have been expected nationally, while a ratio less than 1.0 indicates that fewer deaths than expected occurred.

“Our excellent results not only requires excellent leadership, but intelligent and dedicated staff throughout the transplant and post-transplant process,” said Vinay Nair, DO, medical director of Kidney Transplantation at Northwell Health. “Our outcomes are a testament to our multidisciplinary care team of transplant professionals.”

Northwell started performing adult kidney transplants at NSUH in 2007 and established its pediatric kidney transplant program at Cohen Children’s Medical Center in New Hyde Park in 2017. Today, NSUH offers comprehensive solid organ transplantation services for adult heart, kidney, liver and lung.

To learn more about the Northwell Health’s transplant program, call (516) 472-5800 or go to: https://www.northwell.edu/kidney-transplant.

About Northwell Health

Northwell Health is New York State’s largest health care provider and private employer, with 22 hospitals, 830 outpatient facilities and more than 16,600 affiliated physicians. We care for over two million people annually in the New York metro area and beyond, thanks to philanthropic support from our communities. Our 78,000 employees – 18,900 nurses and 4,900 employed doctors, including members of Northwell Health Physician Partners – are working to change health care for the better. We’re making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Twitter, Instagram and LinkedIn.

Contacts

Jason Molinet
516-321-6705
jmolinet@northwell.edu

Northwell Health


Release Versions

Contacts

Jason Molinet
516-321-6705
jmolinet@northwell.edu

More News From Northwell Health

Feinstein Institutes’ scientists uncover ‘paradigm-shifting’ drug discovery strategy for sepsis, rheumatoid arthritis

MANHASSET, N.Y.--(BUSINESS WIRE)--Scientists at Northwell Health’s Feinstein Institutes for Medical Research have unveiled a novel drug discovery strategy that transforms a previously identified “detrimental” immune element into a potent therapeutic for both sepsis and rheumatoid arthritis (RA). The research, published today in Military Medical Research and led by Haichao Wang, PhD, professor in the Institute of Translational Research at the Feinstein Institutes, demonstrates that a peptide cal...

Northwell’s Feinstein Institutes’ Kevin J. Tracey named to TIME100 2026 Health list

NEW HYDE PARK, N.Y.--(BUSINESS WIRE)--In recognition of Kevin J. Tracey, MD’s decades-long pursuit into unraveling the mysteries of the brain’s connection to the body and control of inflammation through technology, TIME has named the president and CEO of the Feinstein Institutes for Medical Research at Northwell Health an “Innovator” on its 2026 TIME100 Health list. The recognition spotlights 100 of the world’s most influential leaders transforming global health. Read Dr. Tracey’s profile here...

Feinstein Institutes’ Dr. Stephanie Fitzpatrick elected Fellow of the Academy of Behavior Medicine Research

MANHASSET, N.Y.--(BUSINESS WIRE)--For her leadership in behavioral medicine and health equity, Stephanie L. Fitzpatrick, PhD, a clinical health psychologist, behavioral medicine researcher and implementation scientist at Northwell Health’s Feinstein Institutes for Medical Research, has been elected a Fellow of the Academy of Behavioral Medicine Research (ABMR), the premier honorary scientific organization in her field. The ABMR fellowship recognizes Dr. Fitzpatrick for her extensive contributio...
Back to Newsroom